Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
boston blog main
boston top stories
3
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
life sciences
national
national blog main
national top stories
new york blog main
3
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
3
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alzheimer's disease
amgen
cystic fibrosis
deals
diagnostics
eli lilly
gene editing
gilead sciences
glaxosmithkline
indiana blog main
indiana top stories
merck
novartis
pfizer
What
bio
3
×
ceo
3
×
roundup
acquisitions
biggest
crispr
drug
moves
week
albert
big
bosley's
bosley’s
bourla
bridge
bucks
build
buy
cas
company
company’s
crime
daniel
debut
departure
dyne’s
editas
exit
future
gilead
guiding
imports
katrine
maker
maps
measured
medicine
microbiome
openly
o’day
Language
unknown
unset
Current search:
bio
×
photo
×
" san diego top stories "
×
ceo
×
" boston top stories "
×
" new york blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More